1. Analysis of chemical exchange in iridium N-heterocyclic carbene complexes using heteronuclear parahydrogen-enhanced NMR.
- Author
-
Assaf CD, Gui X, Salnikov OG, Brahms A, Chukanov NV, Skovpin IV, Chekmenev EY, Herges R, Duckett SB, Koptyug IV, Buckenmaier K, Körber R, Plaumann M, Auer AA, Hövener JB, and Pravdivtsev AN
- Abstract
The signal amplification by reversible exchange process (SABRE) enhances NMR signals by unlocking hidden polarization in parahydrogen through interactions with to-be-hyperpolarized substrate molecules when both are transiently bound to an Ir-based organometallic catalyst. Recent efforts focus on optimizing polarization transfer from parahydrogen-derived hydride ligands to the substrate in SABRE. However, this requires quantitative information on ligand exchange rates, which common NMR techniques struggle to provide. Here, we introduce an experimental spin order transfer sequence, with readout occurring at
15 N nuclei directly interacting with the catalyst. Enhanced15 N NMR signals overcome sensitivity challenges, encoding substrate dissociation rates. This methodology enables robust data fitting to ligand exchange models, yielding substrate dissociation rate constants with higher precision than classical 1D and 2D1 H NMR approaches. This refinement improves the accuracy of key activation enthalpy ΔH‡ and entropy ΔS‡ estimates. Furthermore, the higher chemical shift dispersion provided by enhanced15 N NMR reveals the kinetics of substrate dissociation for acetonitrile and metronidazole, previously inaccessible via1 H NMR due to small chemical shift differences between free and Ir-bound substrates. The presented approach can be successfully applied not only to isotopically enriched substrates but also to compounds with natural abundance of the to-be-hyperpolarized heteronuclei., Competing Interests: Competing interests: E.Y.C. declares a stake of ownership in XeUS Technologies LTD and Vizma Life Sciences. E.Y.C. serves on the Scientific Advisory Board (SAB) of Vizma Life Sciences. The remaining authors declare no competing interests., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF